Table 2.
Detailed coinfections using the extended respiratory panel (RP2). HCoV (coronavirus (229E, HKU1, NL63, OC43), RSV (respiratory syncytial virus), HMPV (human metapneumovirus), HPIV (human parainfluenza virus).
| Year | Month (Total coinfections, ≥2 targets = 72) | Target 1 | Target 2 | Target 3 | Total |
|---|---|---|---|---|---|
| 2021 | November (23) | enterovirus/rhinovirus | HPIV2 (6), HPIV3 (3), RSVA (1), RSVB (1), | 11 | |
| Adenovirus | enterovirus/rhinovirus (5), HCoV (1) | 6 | |||
| HMPV | enterovirus/rhinovirus (3) | 3 | |||
| SARS-CoV-2 | RSVB (1), HPIV3(1) | 2 | |||
| HPIV2 | RSVB (1) | 1 | |||
| December (25) | Adenovirus | enterovirus/rhinovirus (6), HMPV (1), HCoV (1) | 8 | ||
| enterovirus/rhinovirus | RSVB (2), HPIV2 (1), HPIV3 (2), HPIV4 (1) | 6 | |||
| SARS-CoV-2 | enterovirus/rhinovirus (4) | HPIV3 (1) | 5 | ||
| HCoV | SARS-CoV-2(2), enterovirus/rhinovirus (1) | 3 | |||
| HPIV3 | RSVB (1) | 1 | |||
| Influenza B | Chlamydia pneumoniae (1) | 1 | |||
| HMPV | enterovirus/rhinovirus (1) | 1 | |||
| 2022 | January (15) | Adenovirus | enterovirus/rhinovirus (3), SARS-CoV-2 (2),influenza A(1) | 6 | |
| SARS-CoV-2 | HMPV (1), enterovirus/rhinovirus (4) | 5 | |||
| enterovirus/rhinovirus | HMPV (2) | 2 | |||
| HCoV | HMPV (1), SARS-CoV-2 (1) | 2 | |||
| February (9) | Adenovirus | enterovirus/rhinovirus (5), HCoV (1) | 6 | ||
| SARS-CoV-2 | enterovirus/rhinovirus (2) | 2 | |||
| enterovirus/rhinovirus | HPIV 3 (1) | 1 |